The Latin America, Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market is expected to witness market growth of 11.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of USD178.2 million by 2031. The Argentina market is showcasing a CAGR of 13% during 2024-2031. Additionally, the UAE market would register a CAGR of 11.4% during 2024-2031.
Compliance with regulatory standards and quality improvement initiatives is a key driver for adopting VNA and PACS systems. Healthcare organizations are adopting these systems to ensure adherence to regulations such as HIPAA and DICOM, which mandate secure and standardized handling of imaging data. Additionally, VNA and PACS support quality improvement efforts by providing tools for monitoring and enhancing diagnostic accuracy and patient care.
The need for seamless data interoperability between different healthcare systems drives VNA and PACS solutions adoption. These systems enable the exchange and integration of imaging data across diverse platforms and healthcare networks, facilitating better coordination of care and improving patient outcomes by ensuring that all relevant data is accessible to healthcare providers.
The expansion of investment in addressing non-communicable diseases (NCDs) in Saudi Arabia is having a significant impact on the vendor neutral archive (VNA) and PACS market. With NCDs accounting for 68 percent of all deaths in the country, there is a critical need for advanced healthcare solutions that facilitate efficient data management and improved patient care. The rising healthcare budget in the UAE will lead to increased investment in advanced imaging infrastructure across hospitals and clinics. This will drive the adoption of cutting-edge PACS solutions to support managing and storing high-resolution imaging data.
As per the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. In conclusion, the rising investment in non-communicable diseases in Saudi Arabia and rising healthcare budget in UAE is poised to propel the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others.
The Brazil market dominated the LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of USD178.2 million by 2031. The Argentina market is showcasing a CAGR of 13% during 2024-2031. Additionally, the UAE market would register a CAGR of 11.4% during 2024-2031.
Compliance with regulatory standards and quality improvement initiatives is a key driver for adopting VNA and PACS systems. Healthcare organizations are adopting these systems to ensure adherence to regulations such as HIPAA and DICOM, which mandate secure and standardized handling of imaging data. Additionally, VNA and PACS support quality improvement efforts by providing tools for monitoring and enhancing diagnostic accuracy and patient care.
The need for seamless data interoperability between different healthcare systems drives VNA and PACS solutions adoption. These systems enable the exchange and integration of imaging data across diverse platforms and healthcare networks, facilitating better coordination of care and improving patient outcomes by ensuring that all relevant data is accessible to healthcare providers.
The expansion of investment in addressing non-communicable diseases (NCDs) in Saudi Arabia is having a significant impact on the vendor neutral archive (VNA) and PACS market. With NCDs accounting for 68 percent of all deaths in the country, there is a critical need for advanced healthcare solutions that facilitate efficient data management and improved patient care. The rising healthcare budget in the UAE will lead to increased investment in advanced imaging infrastructure across hospitals and clinics. This will drive the adoption of cutting-edge PACS solutions to support managing and storing high-resolution imaging data.
As per the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. In conclusion, the rising investment in non-communicable diseases in Saudi Arabia and rising healthcare budget in UAE is poised to propel the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others.
List of Key Companies Profiled
- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
Market Report Segmentation
By Product Type
- VNA
- Multi-Department VNA
- Department VNA
- Multi-Site VNA
- PACS
- Multi-Department PACS
- Department PACS
- Multi-Site PACS
By Vendor Type
- Independent Vendor
- Third-party Vendor
By Deployment
- On-Premise
- Cloud-Based
- Hybrid Model
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Others
By Application
- Cardiology
- Orthopedic
- Oncology
- Neurology
- Obstetrics & Gynecology
- Others
By Modality
- Computed Tomography
- Mammography
- MRI
- Ultrasound
- X-Rays
- PET
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
Chapter 6. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
Chapter 7. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
Chapter 8. LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
Chapter 9. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
Chapter 10. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 11. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country
Chapter 12. Company Profiles
Companies Mentioned
Some of the key companies in the LAMEA Vendor Neutral Archive (VNA) & PACS Market include:- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
Methodology
LOADING...
